Bloomage Biotech(SH:688363) Zheng Xing Xing Ye Ri Bao·2026-01-16 09:03Market Overview - The medical beauty sector experienced a decline of 1.79% on January 16, with Huaxi Biological leading the drop [1] - The Shanghai Composite Index closed at 4101.91, down 0.26%, while the Shenzhen Component Index closed at 14281.08, down 0.18% [1] Individual Stock Performance - Jinbo Biological (920982) closed at 235.00, with a slight increase of 0.38% and a trading volume of 6758.42 lots [1] - ST Meigu (000615) closed at 3.43, up 0.29% with a trading volume of 12.66 million [1] - Aimeike (300896) closed at 146.31, down 1.68% with a trading volume of 35,000 [1] - Huaxi Biological (688363) closed at 46.31, down 2.24% with a trading volume of 51,600 [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 112 million yuan from main funds, while retail investors contributed a net inflow of 73.41 million yuan [1] - The detailed capital flow for individual stocks shows: - ST Meigu had a main fund net outflow of 446,500 yuan and a retail net inflow of 198,200 yuan [2] - Jinbo Biological experienced a main fund net outflow of 7.88 million yuan and a retail net outflow of 223,700 yuan [2] - Huaxi Biological had a significant main fund net outflow of 46.59 million yuan, with retail investors contributing a net inflow of 27.27 million yuan [2] - Aimeike faced a main fund net outflow of 64.99 million yuan, while retail investors had a net inflow of 45.95 million yuan [2]